ADK Diagnos Inc

DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the
use of artificial intelligence and advanced knowledge extraction techniques,
announces today a grant of a total of 500,000 stock options to the directors of
the Corporation as approved by the board of directors under the terms of the
Corporation's stock option plan.


Grants of stock options vest at the rate of 33.33% per year, commencing with the
first anniversary of the grant. The exercise price of these options has been
established at $0.10 per share. The expiry date to which these options can be
exercised has been fixed to September 4, 2018.


All monies quoted in this press release shall be stated in lawful money of Canada. 

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX-v: ADK),
with a mission to commercialize technologies combining contextual imaging and
traditional data mining thereby improving decision making processes. DIAGNOS
offers products, services, and solutions to clients in a variety of fields
including healthcare and natural resources.


Neither the TSX Venture Exchange nor its Regulation Service Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


For further information on DIAGNOS, please visit our website at www.diagnos.com
or the SEDAR website at www.sedar.com.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Marc-Andre Massue, Corporate Secretary
DIAGNOS Inc.
450-678-8882


Louis Morin
Bid Capital Markets
514-845-1101

Diagnos (TSXV:ADK)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024

Diagnos (TSXV:ADK)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024